Clinical Trials Directory

Trials / Completed

CompletedNCT05858775

Mapping the Uterine Cervix Stiffness of Pregnant Women at Mid Gestation

MAPVIX: Mapping the Uterine Cervix Stiffness of Pregnant Women at Mid Gestation

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Pregnolia AG · Industry
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The assessment of cervical stiffness plays a major role in obstetrics, for example to assess the risk of preterm birth. The Pregnolia System is a CE-certified measuring device that objectively determines cervical stiffness using a slight negative pressure. The Pregnolia System was developed in Switzerland and resulted from a research project of the ETH and the University Hospital Zurich. Until now, the stiffness of the cervix was examined and individually assessed by palpation (palpation with fingers). The Pregnolia System was developed to make this measurement objective and independent of the examining person. The aim of the study is to measure cervical stiffness at different locations on the cervix to see if there are differences between the measurement locations.

Conditions

Interventions

TypeNameDescription
DEVICEPregnolia SystemCervical stiffness assessment with the Pregnolia System at 3 locations on the uterine cervix.

Timeline

Start date
2023-07-05
Primary completion
2025-10-10
Completion
2025-10-10
First posted
2023-05-15
Last updated
2026-02-05

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05858775. Inclusion in this directory is not an endorsement.